Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 2,792	$ 5,162
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on change in fair value of redeemable warrants	0	3,023
Stock-based compensation expense	8,653	7,104
Depreciation and amortization	1,871	1,772
Accretion and amortization of debt discount and issuance costs	728	196
Deferred income taxes	327	1
Impairment charges related to operating right of use assets	0	393
Amortization and accretion related to operating right of use assets	4,140	4,625
Changes in operating assets and liabilities:
Accounts receivable	75,068	41,021
Prepaid expenses, deposits and other	(6,417)	(4,289)
Deferred contract costs	(2,412)	(1,780)
Accounts payable	2,710	5,605
Accrued compensation, benefits, commissions and other liabilities	(3,842)	(3,940)
Deferred revenue	(46,861)	(11,079)
Net cash provided by operating activities	36,757	47,814
CASH FLOWS USED IN INVESTING ACTIVITIES:
Capital expenditures	(3,144)	(1,455)
Investment purchases	(11,148)	0
Net cash used in investing activities	(14,292)	(1,455)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds related to Common Stock issuances in March 2021 Offering	0	56,965
Payments of professional fees related to Common Stock issuances in March 2021 Offering	(27)	(1,296)
Proceeds from issuance of Credit Facility	0	89,313
Debt issuance costs paid	0	(4,013)
Principal payments on the Credit Facility	(8,375)	(1,125)
Payments to repurchase shares of Series A Preferred Stock	0	(156,753)
Payments of cash dividends on Series A Preferred Stock	0	(12,679)
Payments to repurchase and retire Common Stock	(4,740)	0
Payments for treasury stock	0	(1,116)
Principal payments on capital leases	(235)	(330)
Proceeds from exercise of employee stock options	965	5,044
Net cash used in financing activities	(12,412)	(25,990)
Effect of foreign currency translation changes	(11,050)	(4,838)
Net change in cash, cash equivalents and restricted cash	(997)	15,531
Cash, cash equivalents and restricted cash at beginning of period	119,990	87,909
Cash, cash equivalents and restricted cash at end of period	118,993	103,440
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	2,195	524
Cash paid for income taxes	1,886	3,053
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Underwriter discounts and commissions	0	2,948
Underwriter expenses	0	1,050
Accrued professional fees related to the issuance of Common Stock	0	27
Accrued cash dividends	0	0
Accrued PIK dividends	0	0
Accretion of discount on Series A Preferred Stock	0	2,277
Issuance of Series A Preferred Stock for PIK dividends	0	2,891
Increase in payables for debt issuance costs	0	145
Increase in principal related to the Credit Facility discount	0	28
Decrease in payables for capital expenditures	$ (2)	$ 0